ATLAS / Macro Radar / Reporting / AMLX

Amylyx Pharmaceuticals, Inc. (AMLX) reporting calendar

Amylyx Pharmaceuticals, Inc. files periodic reports with the SEC as AMLX on Nasdaq. Atlas tracks 18 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
25 Jul 2026 – 20 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
18

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open AMLX market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001193125-26-210292
10-K31 Dec 20253 Mar 202662 days0001193125-26-086645
10-Q30 Sep 20256 Nov 202537 days0001193125-25-268059
10-Q30 Jun 20257 Aug 202538 days0001193125-25-174948
10-Q31 Mar 20258 May 202538 days0000950170-25-066363
10-K31 Dec 20244 Mar 202563 days0000950170-25-031309
10-Q30 Sep 20247 Nov 202438 days0000950170-24-122833
10-Q30 Jun 20248 Aug 202439 days0000950170-24-093311
10-Q31 Mar 20249 May 202439 days0000950170-24-056269
10-K31 Dec 202322 Feb 202453 days0000950170-24-018447
10-Q30 Sep 20239 Nov 202340 days0000950170-23-061516
10-Q30 Jun 202310 Aug 202341 days0000950170-23-041335
10-Q31 Mar 202311 May 202341 days0000950170-23-021369
10-K31 Dec 202213 Mar 202372 days0000950170-23-007609
10-Q30 Sep 202210 Nov 202241 days0000950170-22-024465
10-Q30 Jun 202211 Aug 202242 days0000950170-22-016883
10-Q31 Mar 202212 May 202242 days0000950170-22-009695
10-K31 Dec 202131 Mar 202290 days0000950170-22-005157

Source: SEC EDGAR company submissions for CIK 0001658551. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.